INVO Fertility (IVF) Cash from Investing Activities (2016 - 2026)
INVO Fertility's (IVF) quarterly Cash from Investing Activities came in at -$210000.0 in Q1 2026, down 1333.45% year-on-year from $17025.5 in Q1 2025, and down 2504.81% on a QoQ basis from -$8062.0 in Q3 2025.
INVO Fertility (IVF) Cash from Investing Activities (2016 - 2026) Analysis & Trends
INVO Fertility (IVF) has 10 years of Cash from Investing Activities data on file, last reported at -$210000.0 in Q1 2026.
- On a quarterly basis, Cash from Investing Activities fell 1333.45% year-over-year to -$210000.0 in Q1 2026; TTM through Mar 2026 was -$248158.0, a 166.47% decrease from a year earlier, with the FY2024 full-year figure at $363895.0, up 114.59% from the prior year.
- Cash from Investing Activities for Q1 2026 stood at -$210000.0, down from -$8062.0 in the prior quarter.
- Over the last five years, Cash from Investing Activities for IVF reached as high as $393134.0 in Q4 2024 and fell as low as -$2.3 million in Q3 2023.
- Historically, Cash from Investing Activities has averaged -$164023.9 across 5 years, with a median of -$8447.0 in 2023.
- Across the five-year window, Cash from Investing Activities slumped 74973.7% in 2023 and surged 1080.94% in 2024, its largest moves.
- Year by year, Cash from Investing Activities stood at $8583.0 in 2022, then soared by 287.86% to $33290.0 in 2023, then jumped by 1080.94% to $393134.0 in 2024, then sank by 102.05% to -$8062.0 in 2025, then sank by 2504.81% to -$210000.0 in 2026.
- Per Business Quant data, the three most recent Cash from Investing Activities figures were -$210000.0 in Q1 2026, -$8062.0 in Q3 2025, and -$15446.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.10 Bn | 176.81 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 128.79 Bn | 125.91 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 108.97 Bn | 99.75 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 68.57 Bn | 67.12 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 47.64 Bn | 43.97 Bn | 1.29 Bn | -92.80 Mn |
| 6 | GE HealthCare Technologies | 28.40 Bn | 26.11 Bn | 1.98 Bn | -2.50 Bn |
| 7 | Dexcom | 28.32 Bn | 27.20 Bn | 750.30 Mn | -298.50 Mn |
| 8 | Smith & Nephew | 26.94 Bn | 26.36 Bn | - | - |
| 9 | Koninklijke Philips | 25.45 Bn | 22.33 Bn | 2.07 Bn | -475.32 Mn |
| 10 | INVO Fertility | 1.57 Mn | -3.33 Mn | 732,978.00 | -210,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -210,000.00 |
| Mar 31, 2026 | -210,000.00 |
| Sep 30, 2025 | -8,062.00 |
| Sep 30, 2025 | -8,062.00 |
| Jun 30, 2025 | -15,446.00 |
| Jun 30, 2025 | -15,446.00 |
| Mar 31, 2025 | -14,650.00 |
| Mar 31, 2025 | -14,650.00 |
| Dec 31, 2024 | 393,134.00 |
| Dec 31, 2024 | 393,134.00 |
| Jun 30, 2024 | -5,131.00 |
| Jun 30, 2024 | -5,131.00 |
| Mar 31, 2024 | -24,108.00 |
| Mar 31, 2024 | -24,108.00 |
| Dec 31, 2023 | 33,290.00 |
| Dec 31, 2023 | 33,290.00 |
| Sep 30, 2023 | -2.26 Mn |
| Sep 30, 2023 | -2.26 Mn |
| Jun 30, 2023 | -261,505.00 |
| Jun 30, 2023 | -261,505.00 |